Renal outcomes with sodium glucose cotransporter 2 (SGLT2) inhibitor, dapagliflozin, in obese insulin-resistant model

Autor: Jaikumkao, Krit, Pongchaidecha, Anchalee, Chueakula, Nuttawud, Thongnak, Laongdao, Wanchai, Keerati, Chatsudthipong, Varanuj, Chattipakorn, Nipon, Lungkaphin, Anusorn
Zdroj: In BBA - Molecular Basis of Disease June 2018 1864(6) Part A:2021-2033
Databáze: ScienceDirect